Increasing Prevalence of HIV/AIDS to Augment in the Western Blotting Market Growth

 

Western blotting, also known as immunoblotting, protein immunoblot, or western blot, is a widely used analytical technique to detect specific proteins in a sample of tissue homogenate or extract. It is used to separate and identify proteins. Various steps in western blotting include gel electrophoresis, detection of proteins, incubation of membrane, tissue preparation, and blocking to prevent membrane and antibody interactions. It is widely used in diagnostics and confirmatory tests and blood doping tests and qualitative analysis of cells and proteins. It is a subtype of blotting technique used to separate and identify proteins.

Due to its greater accuracy in detecting HIV antibodies, western blotting is preferred over the enzyme-linked immunosorbent assay (ELISA) to detect HIV. However, Compared to ELISA, western blotting gives more effective and accurate results in HIV detection. According to LymeDisease.org, around 52% of chronic diseases show negative results conducted by ELISA, however, the same is found to be positive by western blot. Thus, with the increasing applications of western blotting, the demand for western blotting techniques is also increasing, which in turn, is expected to augment the western blotting market growth.

For instance, in April 2021, Bio-Techne Corporation announced that ProteinSimple, a Bio-Techne brand, released Abby, its next-generation chemiluminescence system that automates traditional Western blotting. Moreover, in June 2019, Thermo Fisher Scientific launched a new western blotting imaging system. A new, easy-to-use imaging platform features a powerful camera and other imaging capabilities to accelerate and streamline analysis. Furthermore, the increasing research and development, automation in western blotting Instruments, growing proteomics market, and increasing demand for personalized medicine are some major factors expected to drive the western blotting market growth.